PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
0.98
-0.03 (-2.83%)
At close: Aug 20, 2025, 9:41 AM
PharmaCyte Biotech Ratios and Metrics
Financials in USD. Fiscal
year is
May - April.
Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
PE Ratio | 0.18 | -0.91 | -2.35 | 0.16 | 3.16 | -7.6 | 2.06 | -2.63 | -97.3 | 555.38 | -10.49 | -7.95 | -6.35 | -15.13 | -12.97 | -4.66 | -11.14 | -14.44 | -5.59 | -6.87 |
PEG Ratio | -0.00 | -0.07 | 0.02 | -0.00 | -0.06 | -0.05 | -0.04 | -0.00 | 0.14 | -5.47 | -0.49 | 1.00 | -0.05 | 0.41 | 0.14 | -1.44 | -0.42 | 0.69 | 0.26 | -0.38 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.16 | 0.28 | 0.32 | 0.29 | 0.43 | 0.39 | 0.40 | 0.56 | 0.67 | 0.71 | 0.75 | 0.57 | 0.40 | 0.51 | 0.55 | 3.34 | 6.40 | 5.74 | 2.57 | 3.89 |
P/FCF Ratio | -8.1 | -21.84 | -13.11 | -41.3 | -51.18 | -106.43 | -11.57 | 97.74 | -170.04 | -101.34 | -32.2 | -45.33 | -30.34 | -155.26 | -36.71 | -15.39 | -45.48 | -74.21 | -16.98 | -44.07 |
P/OCF Ratio | -8.1 | -21.84 | -13.11 | -41.3 | -51.18 | -106.43 | -11.57 | 97.74 | -170.04 | -101.34 | -32.2 | -45.33 | -30.34 | -155.26 | -36.71 | -15.39 | -45.48 | -74.21 | -16.98 | -44.07 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 7.68 | 14.20 | 4.47 | 4.40 | 6.80 | 8.16 | 14.08 | 49.24 | 116.18 | 87.97 | 58.90 | 75.51 | 121.38 | 141.63 | 468.40 | 1.63 | 3.14 | 4.89 | 5.92 | 2.00 |
Current Ratio | 7.68 | 14.20 | 4.47 | 4.40 | 6.80 | 8.16 | 14.08 | 49.24 | 116.18 | 87.97 | 58.90 | 75.51 | 121.38 | 141.63 | 468.40 | 1.63 | 3.14 | 4.89 | 5.92 | 2.00 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -23.93K | -2.19K | -995.19 | -3.04K | -1.4K | -2.27K |
Return on Equity | 0.23 | -0.08 | -0.03 | 0.44 | 0.03 | -0.01 | 0.05 | -0.05 | n/a | n/a | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.18 | -0.14 | -0.1 | -0.11 | -0.14 |
Return on Assets | 0.21 | -0.07 | -0.03 | 0.33 | 0.02 | -0.01 | 0.04 | -0.04 | n/a | n/a | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.15 | -0.13 | -0.09 | -0.11 | -0.12 |
Return on Invested Capital | -0.02 | -0.02 | -0.02 | -0.02 | -0.06 | -0.03 | -0.02 | -0.03 | -0.01 | n/a | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.18 | -0.15 | -0.1 | -0.11 | -0.14 |
Dividend Yield | n/a | n/a | 1.17 | n/a | 1.32M | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | -11.01 | n/a | 16.67M | n/a | n/a | -0.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |